Phase II study of ‘high-dose’ celecoxib and metronomic ‘low-dose’ cyclophosphamide and methotrexate in patients with relapsed and refractory lymphoma

por Abdel-Bary, N, Hashem, T, Metwali, H, Abd el Ghany, A, Magied, HA, El-Herbeiny, M
Publicado 2009